Korea-Africa partnership for advancing vaccine end-to-end capabilities

The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...

November 27, 2024 | Wednesday | News
Sanofi, A*STAR and NSC collaborate to advance Acne Vaccine R&D in Singapore

Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...

November 22, 2024 | Friday | News
Asia-Pacific Takes the Lead in Vaccine Innovations: Transforming Public Health with Prophylactic and Therapeutic Breakthroughs

Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...

November 25, 2024 | Monday | Analysis
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan

Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...

November 18, 2024 | Monday | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH

Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...

October 29, 2024 | Tuesday | News
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia

SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...

October 23, 2024 | Wednesday | News
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...

October 13, 2024 | Sunday | News
China's CanSino receives over $17 M from Bill & Melinda Gates Foundation to accelerate polio vaccine development

China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...

October 10, 2024 | Thursday | News
SK bioscience invests $3 M in US-based FinaBio specialising in next-gen conjugate vaccine technology

South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...

October 8, 2024 | Tuesday | News
Cenra Healthcare to promote Moderna’s mRNA respiratory vaccine portfolio in Taiwan

Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...

October 1, 2024 | Tuesday | News
Singapore HSA approves Abrysvo Vaccine by Pfizer to combat Respiratory Syncytial Virus (RSV)

Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...

September 25, 2024 | Wednesday | News
WHO prequalifies first vaccine against mpox

The World Health Organization (WHO) has announced MVA-BN vaccine as the first vaccine against mpox to be added to its pr...

September 16, 2024 | Monday | News
Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain

Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...

September 13, 2024 | Friday | News
GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...

September 13, 2024 | Friday | News
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies

Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...

September 12, 2024 | Thursday | News
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan

Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...

September 10, 2024 | Tuesday | News
Moderna’s COVID-19 mRNA vaccine targeting SARS-COV-2 Variant JN.1 receives approval in Taiwan

Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...

September 4, 2024 | Wednesday | News
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines

  Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...

September 2, 2024 | Monday | News